紙本診斷市場規模、佔有率和成長分析（按產品、設備類型、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年醫療診斷市場規模價值 151.8 億美元，預計將從 2024 年的 163.8 億美元成長到 2032 年的 300.9 億美元，預測期內（2025-2032 年）的複合年成長率為 7.9%。

紙本診斷市場已實現顯著成長，因為它為就地檢驗提供了一種便捷且經濟的選擇，尤其是在偏遠和資源有限的地區。這些設備利用紙基基底，能夠快速且準確地診斷一系列疾病，包括瘧疾、愛滋病毒和糖尿病，並且只需要極少的設備和技術專長。生產成本低、易於處理、適用於環境監測和食品安全等應用等優勢正在推動需求。其在醫療資源匱乏的地區推行分散式醫療保健解決方案進一步提升了其受歡迎程度。然而，仍存在挑戰，例如確保可靠的結果、保持穩定性以及擴大分析物檢測範圍。持續的研究、改進的製造方法以及醫療保健提供者和行業相關人員之間的合作預計將推動該市場向前發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

論文診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 量油尺
• 橫向流動化驗
• 紙基微流體

紙本診斷市場規模（按設備類型和複合年成長率） (2025-2032)

• 市場概況
• 監控設備
• 診斷設備

論文診斷市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 環境監測
• 臨床診斷
• 食品品質檢測

論文診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 家庭醫療保健
• 輔助生活保健設施
• 醫院和診所

論文 診斷市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Bio-Rad Laboratories（USA）
• Siemens Healthineers（Germany）
• Abcam Plc（UK）
• Chembio Diagnostic Systems Inc.（USA）
• ACON Laboratories Inc.（USA）
• FFEI（UK）
• ARKRAY Inc.（Japan）
• Creative Diagnostics（USA）
• OraSure Technologies, Inc.（USA）
• Quidel Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Roche Diagnostics（Switzerland）
• PerkinElmer Inc.（USA）
• Sysmex Corporation（Japan）
• bioMerieux SA（France）
• Hologic, Inc.（USA）
• Merck KGaA（Germany）

結論和建議

Paper Diagnostics Market size was valued at USD 15.18 billion in 2023 and is poised to grow from USD 16.38 billion in 2024 to USD 30.09 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The paper diagnostics market is witnessing significant growth as an accessible and economical option for point-of-care testing, especially in remote and resource-limited areas. By utilizing paper-based substrates, these devices enable swift and accurate medical diagnoses for various diseases, including malaria, HIV, and diabetes, while requiring minimal equipment and technical expertise. Their advantages, such as low production costs, easy disposal, and versatility in applications like environmental monitoring and food safety, are driving demand. The push for decentralized healthcare solutions in underserved regions further enhances their popularity. However, challenges like ensuring result reliability, maintaining stability, and broadening analyte detection persist. Continued research, improved manufacturing methods, and collaborations among healthcare providers and industry stakeholders are expected to propel this market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Paper Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Paper Diagnostics Market Segments Analysis

Global Paper Diagnostics Market is segmented by Product, Device Type, Application, End-User and region. Based on Product, the market is segmented into Dipsticks, Lateral Flow Assays and Paper-Based Microfluidics. Based on Device Type, the market is segmented into Monitoring Devices and Diagnostic Devices. Based on Application, the market is segmented into Environmental Monitoring, Clinical Diagnostics and Food Quality Testing. Based on End-User, the market is segmented into Home Healthcare, Assisted Living Healthcare Facilities and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Paper Diagnostics Market

The Paper Diagnostics market is driven by the increasing demand for point-of-care testing solutions that are both rapid and cost-effective. These diagnostic tools facilitate immediate diagnosis and treatment, making them particularly valuable in resource-limited or rural areas lacking access to conventional laboratory facilities. By providing a convenient and efficient means of conducting tests on-site, paper diagnostics help bridge the gap in healthcare availability, ensuring timely interventions and improved patient outcomes. The ability to obtain results swiftly and affordably positions this market as a crucial component in the broader healthcare landscape, addressing the needs of underserved populations effectively.

Restraints in the Paper Diagnostics Market

The dependence of healthcare systems on conventional diagnostic methods poses a significant challenge for the paper diagnostics market, as it hinders the integration or substitution of these innovations in certain contexts. Many established healthcare institutions are accustomed to using traditional diagnostic techniques, which can limit their willingness to adopt newer paper-based solutions. This reliance on established practices creates a barrier to the acceptance and implementation of paper diagnostics, ultimately restraining market growth and reducing the potential for innovation in the field. As a result, overcoming this resistance remains a crucial factor for the advancement of paper diagnostics.

Market Trends of the Paper Diagnostics Market

The Paper Diagnostics market is experiencing a notable upswing, propelled by the rise of Point-of-Care Testing (POCT). This trend is largely fueled by the growing demand for rapid and convenient diagnostic solutions that align with the decentralized healthcare model. Paper-based diagnostics offer a crucial advantage by providing immediate results without the need for complex machinery or specialized personnel, making them ideal for various healthcare settings, including remote and resource-limited areas. As healthcare providers increasingly prioritize efficiency and accessibility, the Paper Diagnostics market is expected to flourish, catering to the evolving needs of patients and healthcare professionals alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Paper Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Dipsticks
• Lateral Flow Assays
• Paper-Based Microfluidics

Global Paper Diagnostics Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Monitoring Devices
• Diagnostic Devices

Global Paper Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Environmental Monitoring
• Clinical Diagnostics
• Food Quality Testing

Global Paper Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Home Healthcare
• Assisted Living Healthcare Facilities
• Hospitals and Clinics

Global Paper Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Device Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Device Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Device Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Device Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Device Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FFEI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations